14 results found.

Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), or Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 4 years or older.
- Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases.

Diabetic Retinopathy, or Macular Edema Clinical Trial using Tromethamine ketorolac; Nepafenac; Polietilenglicol 400, propilenglicol, HP guar

Hospital Juarez de Mexico - Recruiting 40 years to 80 years.
- Efficacy of Topic Antiinflammatory Therapy Treatment in Center Point Thickness Secondary to Selective Photocoagulation in Diabetic Macular Edema.
Tromethamine ketorolac; Nepafenac; Polietilenglicol 400, propilenglicol, HP guar

Proliferative Diabetic Retinopathy, or Macular Edema Clinical Trial using Ketorolac tromethamine; Alcohol polivinilico

Hospital Juarez de Mexico - Recruiting 40 years to 75 years.
- Efficacy and Safety of Topic Ketorolac to Treat Center Point Thickness Secondary to Panphotocoagulation in Proliferative Diabetic Retinopathy.
Ketorolac tromethamine; Alcohol polivinilico

Proliferative Diabetic Retinopathy (PDR) Clinical Trial using Ranibizumab; Laser photocoagulation; Ranibizumab & laser photocoagulation

Novartis - Recruiting 18 years or older.
- Multicenter Randomized Open-label Three-arms Controlled 12 Months Clinical Proof of Concept Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy.
Ranibizumab; Laser photocoagulation; Ranibizumab & laser photocoagulation

Proliferative Diabetic Retinopathy Clinical Trial using Macugen; Sham

Greater Houston Retina Research - Recruiting 18 years or older.
- A Phase III Randomized 1:1, Masked, Study of the Safety, Tolerability, and Efficacy of Intravitreal Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Adjuvant Management of TRD and Vit Hem Associated With PDR.
Macugen; Sham

Choroidal Neovascularization, Macular Edema, Glaucoma, Neovascula Clinical Trial using ranibizumab

Novartis - Recruiting 18 years or older.
- An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases..
ranibizumab

Non-Proliferative Diabetic Retinopathy, or Cataract Clinical Trial using Nepafenac Ophthalmic Suspension, 0.3%; Nepafenac Vehicle; Prednisolone acetate ophthalmic suspension

Alcon Research - Recruiting 18 years or older.
- Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery.
Nepafenac Ophthalmic Suspension, 0.3%; Nepafenac Vehicle; Prednisolone acetate ophthalmic suspension

Non-Proliferative Diabetic Retinopathy, or Cataract Clinical Trial using Nepafenac Ophthalmic Suspension, 0.3%; Nepafenac vehicle; Prednisolone acetate ophthalmic suspension

Alcon Research - Recruiting 18 years or older.
- Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery.
Nepafenac Ophthalmic Suspension, 0.3%; Nepafenac vehicle; Prednisolone acetate ophthalmic suspension

Inflammation Clinical Trial using Acuvail; Placebo

Vanderbilt University - Recruiting 18 years to 90 years.
- The Role of Prostaglandins in the Progression of Diabetic Retinopathy and the Therapeutic Efficacy of Topical Ketorolac (Acuvail).
Acuvail; Placebo

Proliferative Diabetic Retinopathy, or Macular Edema Clinical Trial using laser treatment with PASCALr; laser treatment with conventional laser system

Medical University of Vienna - Recruiting 18 years to 90 years.
- Morphological and Functional Retinal Changes Following Retinal Photocoagulation Using a Semiautomated Patterned Scanning Laser System in Proliferative Retinopathy or Macular Edema Secondary to Diabetes Mellitus or Retinal Vein Occlusion.
laser treatment with PASCALr; laser treatment with conventional laser system

Severe Non-proliferative Diabetic Retinopathy Clinical Trial using T-PRP; S-PRP

Sun Yat-sen University - Recruiting 45 years to 80 years.
- Randomized, Parallel Controlled, Clinical-trial on 532nm Laser Partially Subthreshold Panretinal Photocoagulation With PASCAL Endpoint Management Function for Severe Non-proliferative Diabetic Retinopathy(NPDR).
T-PRP; S-PRP

Diabetes Mellitus, or Diabetic Retinopathy Clinical Trial using Insulin pump; Multiple daily insulin injections; Bariatric surgery; Medical therapy for type 2 diabetes

Glostrup University Hospital, Copenhagen - Recruiting 18 years or older.
- Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes.
Insulin pump; Multiple daily insulin injections; Bariatric surgery; Medical therapy for type 2 diabetes